<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Contrasting Global and Patient-Specific Regression Models via a Neural Network Representation - Health AI Hub</title>
    <meta name="description" content="This paper introduces a diagnostic tool designed to contrast global clinical prediction models with patient-specific (local) models, aiming to identify where an">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Contrasting Global and Patient-Specific Regression Models via a Neural Network Representation</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2601.18658v1" target="_blank">2601.18658v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2026-01-26
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Max Behrens, Daiana Stolz, Eleni Papakonstantinou, Janis M. Nolde, Gabriele Bellerino, Angelika Rohde, Moritz Hess, Harald Binder
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> stat.ME, stat.ML
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.95 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2601.18658v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2601.18658v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper introduces a diagnostic tool designed to contrast global clinical prediction models with patient-specific (local) models, aiming to identify where and for whom a global model may be inadequate. The approach utilizes localized regression in a dimension-reduced latent space derived from an autoencoder, enabling the identification and characterization of patient subgroups whose outcomes deviate from the global model. Applied to a COPD study, it revealed that while a global model sufficed for most, specific subgroups indeed benefited from personalized models.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research is crucial for advancing personalized medicine by providing a systematic way to determine when and for whom a personalized approach to prediction or risk stratification is superior to a 'one-size-fits-all' model, leading to more accurate clinical decision-making and tailored patient care.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>This paper applies neural networks (specifically autoencoders for dimension reduction) to develop advanced clinical prediction models. Its AI application is to identify patient subgroups within a medical context (e.g., COPD patients) for whom global prediction models are inadequate, thereby enabling more personalized risk assessment, diagnosis, or treatment strategies. This enhances the utility of AI in tailoring medical interventions and improving patient outcomes.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Addresses the critical challenge in clinical prediction model development of balancing global models (valid for all) with personalized models (tailored to individuals or subgroups).</li>
                    
                    <li>Proposes a diagnostic tool to identify patients or subgroups for whom a global regression model is inadequate, suggesting where personalized approaches are needed.</li>
                    
                    <li>Employs a localized regression method that operates on a dimension-reduced latent representation of the predictor space.</li>
                    
                    <li>The latent representation is generated by an autoencoder, which is optimized to simultaneously achieve good data reconstruction and reveal local outcome-related associations suitable for robust localized regression.</li>
                    
                    <li>Illustrates the approach using a clinical study involving patients with Chronic Obstructive Pulmonary Disease (COPD).</li>
                    
                    <li>Findings indicate that the global model adequately predicts outcomes for most patients, but identifies specific, definable subgroups that significantly benefit from personalized models.</li>
                    
                    <li>The tool provides a mechanism to map subgroup-specific models back to the original predictors, offering insights into the characteristics that make the global model fall short for these groups.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The study proposes a diagnostic tool that contrasts global and patient-specific regression models. It utilizes a localized regression approach to pinpoint regions in the predictor space where patients are poorly represented by a global model. To overcome challenges with high-dimensional data, the method first reduces dimensionality by learning a latent representation using an autoencoder. This neural network architecture is specifically designed to optimize for both accurate data reconstruction and the ability to reveal local outcome associations, making it suitable for robust localized regression.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The application of the proposed tool in a clinical study of COPD patients revealed that, while a global prediction model was sufficient for the majority of individuals, specific subgroups existed for whom personalized models offered superior predictive accuracy. A key finding is the ability to not only identify these subgroups but also to map their unique outcome associations back to the original predictors, thus providing actionable insights into why the global model was inadequate for these particular patient groups.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This tool can significantly impact clinical practice by guiding the development and deployment of prediction models. It enables clinicians and researchers to objectively determine when a global model is sufficient or when resources should be invested in developing and applying personalized models for specific patient subgroups. This can lead to improved risk stratification, more accurate prognoses, and the development of tailored treatment strategies, ultimately enhancing patient outcomes and fostering more precise, personalized healthcare.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state any limitations of the proposed method or its application.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The abstract does not explicitly state future research directions for this work.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Pulmonology</span>
                    
                    <span class="tag">Personalized Medicine</span>
                    
                    <span class="tag">Clinical Informatics</span>
                    
                    <span class="tag">Biostatistics</span>
                    
                    <span class="tag">General Medicine</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Clinical prediction models</span>
                    
                    <span class="tag tag-keyword">Personalized medicine</span>
                    
                    <span class="tag tag-keyword">Localized regression</span>
                    
                    <span class="tag tag-keyword">Autoencoder</span>
                    
                    <span class="tag tag-keyword">Dimension reduction</span>
                    
                    <span class="tag tag-keyword">Subgroup identification</span>
                    
                    <span class="tag tag-keyword">Chronic Obstructive Pulmonary Disease</span>
                    
                    <span class="tag tag-keyword">Diagnostic tool</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">When developing clinical prediction models, it can be challenging to balance between global models that are valid for all patients and personalized models tailored to individuals or potentially unknown subgroups. To aid such decisions, we propose a diagnostic tool for contrasting global regression models and patient-specific (local) regression models. The core utility of this tool is to identify where and for whom a global model may be inadequate. We focus on regression models and specifically suggest a localized regression approach that identifies regions in the predictor space where patients are not well represented by the global model. As localization becomes challenging when dealing with many predictors, we propose modeling in a dimension-reduced latent representation obtained from an autoencoder. Using such a neural network architecture for dimension reduction enables learning a latent representation simultaneously optimized for both good data reconstruction and for revealing local outcome-related associations suitable for robust localized regression. We illustrate the proposed approach with a clinical study involving patients with chronic obstructive pulmonary disease. Our findings indicate that the global model is adequate for most patients but that indeed specific subgroups benefit from personalized models. We also demonstrate how to map these subgroup models back to the original predictors, providing insight into why the global model falls short for these groups. Thus, the principal application and diagnostic yield of our tool is the identification and characterization of patients or subgroups whose outcome associations deviate from the global model.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>